Close Menu

On Patents

There is little evidence for all the concern over gene patents hurting basic biomedical research, writes Timothy Caulfield at Science Progress. Caulfield, who studies health law and policy at the University of Alberta, says the justification makes logical sense and has some anecdotal evidence, but there is a lack of hard data. Furthermore, he says this debate overshadows the effect that "commercialization pressure" has on academic research.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal reports on gaps in COVID-19 testing affecting less affluent urban areas and rural locations.

According to NBC News, new SARS-CoV-2 variants are making it harder for researchers to model the course of the pandemic.

The New York Times reports that experts say President Joe Biden's goal of vaccinating 1 million people a day in the US in the next 100 days is too low a bar.

In Science this week: single-cell lineage tracing technique applied to study lung cancer metastasis, and more.